Israeli digital therapy company Medisafe has announced the completion of a $ 30 million Series C financing round led by Sanofi Ventures and ALIVE Israel HealthTech Fund, with Leumi Partners, Menorah Mivtachim, Consensus Business Group and former investors Pitango HealthTech, 7wireVentures, Merck Ventures, Octopus Ventures and lool Ventures, Triventures, Qualcomm Ventures, and OurCrowd. Related articles drug management company Medisafe collects $ 14.5 million. Medisafe, which helps patients adhere to their prescribed medications, will use the new funding to expand its comprehensive solutions that support patient drug management and accelerate revenue growth. Chris De Luca, Global Head of Digital Investments at Sanofi Ventures, and David Klein, Co-Founder, Managing Partner, ALIVE Israel HealthTech Fund, will join the Medisafe Board of Directors. With offices in Haifa and Boston, Medisafe was founded in 2012 by CEO Omri Shor and CTO Rotem Shor. The company’s drug management platform has more than seven million registered users globally and is rapidly growing as the healthcare sector transforms into digital health solutions to support patients. Medisafe deploys digital medication companions to comprehensively support patients throughout their treatment journey using advanced technology that transforms patient behaviors supported by JITI (Just-in-Time Interventions), a personalized AI data-driven engine that provides patient support. Over the past eight years, Medisafe has amassed a database of over four billion dose behaviors to inform JITI for increased engagement and leadership outcomes. Omri Shor said: “This investment allows Medisafe to expand its comprehensive treatment support for patients to ultimately influence behavior and outcome change. Medisafe is constantly developing its technology to meet the dynamic needs of patients who administer complex therapies. The future model for patient support is not purely digital but is adaptive to enable In fact, we’re seeing impressive results connecting clinicians and caregivers to support solutions with 4-fold accreditation rates compared to pure digital and 1.8-fold increase in nurse-patient contact. We are excited to build more capabilities to meet the evolving needs of the industry. “Posted by Globes, Israel business news – en.globes.co.il – on February 28, 2021 © Copyright Globes Publisher Itonut (1983) Ltd. 2021
Digital therapy company Medisafe raises $ 30 million
0 Comments